T. Rowe Price Investment Management, Inc. - INNOVAGE HLDG CORP ownership

INNOVAGE HLDG CORP's ticker is INNV and the CUSIP is 45784A104. A total of 55 filers reported holding INNOVAGE HLDG CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of INNOVAGE HLDG CORP
ValueSharesWeighting
Q3 2023$28,194
-24.5%
4,706,714
-5.4%
0.02%
-20.0%
Q2 2023$37,330
-8.8%
4,977,307
-3.0%
0.02%
-13.8%
Q1 2023$40,941
+8.7%
5,130,352
-2.2%
0.03%0.0%
Q4 2022$37,675
-99.9%
5,247,106
+4.5%
0.03%
+20.8%
Q3 2022$29,536,0005,022,9700.02%
Other shareholders
INNOVAGE HLDG CORP shareholders Q4 2022
NameSharesValueWeighting ↓
COURAGE CAPITAL MANAGEMENT LLC 207,000$5,339,0003.90%
Monashee Investment Management LLC 250,000$6,448,0000.99%
SECTORAL ASSET MANAGEMENT INC 479,794$12,374,0000.94%
INHERENT GROUP, LP 231,214$5,963,0000.84%
Sivik Global Healthcare LLC 85,000$2,192,0000.80%
Camber Capital Management LP 650,000$16,764,0000.58%
PFM Health Sciences, LP 429,699$11,082,0000.34%
Redmile Group, LLC 850,000$21,922,0000.31%
HealthCor Management, L.P. 325,000$8,382,0000.30%
Rock Springs Capital Management LP 475,000$12,250,0000.27%
View complete list of INNOVAGE HLDG CORP shareholders